Enanta Pharmaceuticals Inc (ENTA): ENTA’s PR on phase-1 data for EDP-323, a...

Next 10 Prev Next

Send PM Follow Ignore

Re: JK2016 post# 2577

Tuesday, 06/20/2023 10:37:15 AM

Tuesday, June 20, 2023 10:37:15 AM

ENTA’s PR on phase-1 data for EDP-323, an RSV L-protein inhibitor:

https://ir.enanta.com/news-releases/news-release-details/enanta-pharmaceuticals-announces-positive-data-phase-1-0

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Next 10 Prev Next

Go Ad-Free